What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
FY2025 Financial Results Summary [Japanese GAAP] (Consolidated)
Page 15 of the attached materials, 3. Consolidated Financial Statements and Principal Notes, (5) Notes to the Consolidated Financial Statements, (Notes to Segment Information and Other Matters), 3. Information on the amounts of sales, profit or loss, assets, liabilities and other items by reportable segment, "Additions to property, plant and equipment and intangible assets"
Previous fiscal year (from 1 July 2023 to 30 June 2024) Medical Device Sales Business ¥1,294,148 thousand / Nursing-care and welfare business ¥443,995 thousand / Total ¥1,738,144 thousand / Adjustments ¥735,612 thousand / Amount reported in the consolidated financial statements ¥2,473,757 thousand / Current fiscal year (from 1 July 2024 to 30 June 2025) Medical Device Sales Business ¥1,858,178 thousand / Nursing-care and welfare business ¥433,151 thousand / Total ¥2,291,330 thousand / Adjustments ¥445,131 thousand / Amount reported in the consolidated financial statements ¥2,736,461 thousand
Previous fiscal year (from 1 July 2023 to 30 June 2024) Medical Device Sales Business ¥1,292,869 thousand / Nursing-care and welfare business ¥443,995 thousand / Total ¥1,736,865 thousand / Adjustments ¥1,676,056 thousand / Amount reported in the consolidated financial statements ¥3,412,921 thousand / Current fiscal year (from 1 July 2024 to 30 June 2025) Medical Device Sales Business ¥1,858,178 thousand / Nursing-care and welfare business ¥433,151 thousand / Total ¥2,291,330 thousand / Adjustments ¥475,131 thousand / Amount reported in the consolidated financial statements ¥2,766,461 thousand
The correction is being made because it was discovered that part of the amount of additions to property, plant and equipment and intangible assets in the notes to segment information and other matters had been aggregated incorrectly.
| Item | Details |
|---|---|
| Disclosure subject to correction | FY2025 Financial Results Summary [Japanese GAAP] (Consolidated) |
| Original disclosure date | 7 August 2025 |
| Location of correction | Page 15 of the attached materials, 3. Consolidated Financial Statements and Principal Notes, (5) Notes to the Consolidated Financial Statements, (Notes to Segment Information and Other Matters), 3. Information on the amounts of sales, profit or loss, assets, liabilities and other items by reportable segment, "Additions to property, plant and equipment and intangible assets" |
| Details of correction | Previous fiscal year (from 1 July 2023 to 30 June 2024) Medical Device Sales Business ¥1,294,148 thousand / Nursing-care and welfare business ¥443,995 thousand / Total ¥1,738,144 thousand / Adjustments ¥735,612 thousand / Amount reported in the consolidated financial statements ¥2,473,757 thousand / Current fiscal year (from 1 July 2024 to 30 June 2025) Medical Device Sales Business ¥1,858,178 thousand / Nursing-care and welfare business ¥433,151 thousand / Total ¥2,291,330 thousand / Adjustments ¥445,131 thousand / Amount reported in the consolidated financial statements ¥2,736,461 thousand → Previous fiscal year (from 1 July 2023 to 30 June 2024) Medical Device Sales Business ¥1,292,869 thousand / Nursing-care and welfare business ¥443,995 thousand / Total ¥1,736,865 thousand / Adjustments ¥1,676,056 thousand / Amount reported in the consolidated financial statements ¥3,412,921 thousand / Current fiscal year (from 1 July 2024 to 30 June 2025) Medical Device Sales Business ¥1,858,178 thousand / Nursing-care and welfare business ¥433,151 thousand / Total ¥2,291,330 thousand / Adjustments ¥475,131 thousand / Amount reported in the consolidated financial statements ¥2,766,461 thousand |
| Reason for correction | The correction is being made because it was discovered that part of the amount of additions to property, plant and equipment and intangible assets in the notes to segment information and other matters had been aggregated incorrectly. |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.It was discovered that part of the amount of additions to property, plant and equipment and intangible assets in the notes to segment information and other matters had been aggregated incorrectly.